Open Access

Upregulated miR‑665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion

  • Authors:
    • Jinbing Xia
    • Dengping Li
    • Xiaoliang Zhu
    • Wenying Xia
    • Zhenyong Qi
    • Guanhua Li
    • Qian Xu
  • View Affiliations

  • Published online on: March 11, 2020     https://doi.org/10.3892/ol.2020.11457
  • Pages: 3578-3586
  • Copyright: © Xia et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Non-small cell lung cancer (NSCLC) is one of the leading causes of global cancer-associated mortality. Aberrant microRNAs (miRs) have been reported to be involved in the pathogenesis of various cancer types. The present study aimed to investigate the expression profile and prognostic value of miR‑665 in patients with NSCLC, and to analyze its functional role in tumor progression using NSCLC cells. Reverse transcription‑quantitative PCR was used to estimate the expression levels of miR‑665. Kaplan‑Meier survival curves and Cox regression analysis were performed to evaluate the prognostic value of miR‑665. The effects of miR‑665 on NSCLC cell proliferation, migration and invasion were examined by cell transfection, and the target gene of miR‑665 was explored. miR‑665 expression was elevated in the tissue and cell samples of NSCLC. This increased miR‑665 expression was associated with lymph node metastasis and TNM stage. An independent association between miR‑665 and overall survival was identified in patients with NSCLC. When regulating the expression levels of miR‑665 in vitro, NSCLC cell proliferation, migration and invasion were enhanced by overexpression of miR‑665, but were inhibited by knockdown of miR‑665. The luciferase activity results indicated that the protein tyrosine phosphatase receptor type B (PTPRB) was a direct target of miR‑665 in NSCLC cells. The present study provided evidence for the clinical significance of a decreased expression of miR‑665 in the prognosis of NSCLC. Upregulation of miR‑665 contributed to tumor cell proliferation, migration and invasion by targeting PTPRB, suggesting the potential of miR‑665 as a candidate therapeutic target for NSCLC treatment.

Related Articles

Journal Cover

May 2020
Volume 19 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Xia, J., Li, D., Zhu, X., Xia, W., Qi, Z., Li, G., & Xu, Q. (2020). Upregulated miR‑665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion. Oncology Letters, 19, 3578-3586. https://doi.org/10.3892/ol.2020.11457
MLA
Xia, J., Li, D., Zhu, X., Xia, W., Qi, Z., Li, G., Xu, Q."Upregulated miR‑665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion". Oncology Letters 19.5 (2020): 3578-3586.
Chicago
Xia, J., Li, D., Zhu, X., Xia, W., Qi, Z., Li, G., Xu, Q."Upregulated miR‑665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion". Oncology Letters 19, no. 5 (2020): 3578-3586. https://doi.org/10.3892/ol.2020.11457